GRNA
Price:
$0.2995
Market Cap:
$45.43M
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
Industry
Biotechnology
IPO Date
2022-02-03
Stock Exchange
NASDAQ
Ticker
GRNA
According to GreenLight Biosciences Holdings’s latest financial reports and current stock price. The company's current PE Ratio is -0.27. This represents a change of -78.54% compared to the average of -1.25 of the last 4 quarters.
The mean historical PE Ratio of GreenLight Biosciences Holdings over the last ten years is -15.39. The current -0.27 PE Ratio has changed 73.79% with respect to the historical average. Over the past ten years (40 quarters), GRNA's PE Ratio was at its highest in in the December 2021 quarter at 4.68. The PE Ratio was at its lowest in in the December 2020 quarter at -13.50.
Average
-15.39
Median
-14.01
Minimum
-32.60
Maximum
-0.93
Discovering the peaks and valleys of GreenLight Biosciences Holdings PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.93
Minimum Annual Increase = -91.22%
Minimum Annual PE Ratio = -32.60
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -0.93 | -91.22% |
| 2021 | -10.62 | -38.95% |
| 2020 | -17.40 | -46.63% |
The current PE Ratio of GreenLight Biosciences Holdings (GRNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.65
5-year avg
-15.39
10-year avg
-15.39
GreenLight Biosciences Holdings’s PE Ratio is less than Lunai Bioworks Inc. (-0.24), less than bluebird bio, Inc. (-0.24), greater than Spyre Therapeutics, Inc. (-77.56), greater than Rein Therapeutics Inc. (-0.61), less than Magenta Therapeutics, Inc. (-0.02), greater than AlloVir, Inc. (-2.14), greater than Pluristem Therapeutics Inc. (-55.09), less than ERYTECH Pharma S.A. (-0.02), less than LianBio (4.68), greater than Satsuma Pharmaceuticals, Inc. (-0.51),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.24 | $32.92M | |
| -0.24 | $48.67M | |
| -77.56 | $2.02B | |
| -0.61 | $35.75M | |
| -0.02 | $42.44M | |
| -2.14 | $49.48M | |
| -55.09 | $40.85M | |
| -0.02 | $47.38M | |
| 4.68 | $11.68M | |
| -0.51 | $36.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GreenLight Biosciences Holdings using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GreenLight Biosciences Holdings or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is GreenLight Biosciences Holdings's PE Ratio?
How is the PE Ratio calculated for GreenLight Biosciences Holdings (GRNA)?
What is the highest PE Ratio for GreenLight Biosciences Holdings (GRNA)?
What is the 3-year average PE Ratio for GreenLight Biosciences Holdings (GRNA)?
What is the 5-year average PE Ratio for GreenLight Biosciences Holdings (GRNA)?
How does the current PE Ratio for GreenLight Biosciences Holdings (GRNA) compare to its historical average?